Senores Pharmaceuticals Limited has informed the Exchange regarding additional disclosures to the Notice of Extra-Ordinary General Meeting dated January 07, 2026.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals Limited has submitted additional disclosures to the Exchange related to the Notice of its Extra-Ordinary General Meeting (EGM) originally dated January 07, 2026. This is a supplementary filing, meaning the company is providing extra information or clarifications to shareholders ahead of the EGM. The exact nature of the additional disclosures is not detailed in the headline. Shareholders should review the updated EGM notice carefully, as supplementary disclosures often include revised proposals, clarifications on resolutions, or newly added agenda items.
This is a procedural update with no direct impact on stock price. Shareholders planning to attend or vote at the EGM should check the updated notice for any changes to the agenda or new disclosures that could affect their voting decisions.